Psychedelics & brain tech tested in groundbreaking suicide risk study
NCT ID NCT07484906
Summary
This study aimed to better understand who is at high risk for suicide. Researchers planned to use brain scans, blood tests, and AI to find patterns. They also wanted to test three experimental therapies—brain stimulation, neurofeedback, and psilocybin (a psychedelic)—to see if they could reduce suicidal thoughts. The study was withdrawn before any participants were enrolled.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SUICIDAL IDEATION are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.